Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development (Q45385614)

14 December 2017

title

Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development (English)

1 reference

14 December 2017

1 reference

Zhang Jinyong

1

1 reference

14 December 2017

Zhang Xiaoli

2

1 reference

14 December 2017

Zhang Weijun

3

1 reference

14 December 2017

Guo Ying

4

1 reference

14 December 2017

Guo Gang

5

1 reference

14 December 2017

Mao Xuhu

6

1 reference

14 December 2017

Zou Quanming

7

1 reference

14 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20878241

22 July 2024

publication date

28 September 2010

1 reference

full work available at URL

14 December 2017

http://link.springer.com/content/pdf/10.1007/s11033-010-0317-6.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S11033-010-0317-6

http://link.springer.com/article/10.1007/s11033-010-0317-6/fulltext.html

22 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0317-6

http://link.springer.com/content/pdf/10.1007/s11033-010-0317-6

22 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11033-010-0317-6

Molecular Biology Reports

22 July 2024

published in

1 reference

14 December 2017

volume

38

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

1957-1963

1 reference

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Modulation of Bordetella pertussis Infection with Monoclonal Antibodies to Pertussis Toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Bordetella pertussis infection of human respiratory epithelial cells up-regulates intercellular adhesion molecule-1 expression: role of filamentous hemagglutinin and pertussis toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Expression of an olfactory receptor in Escherichia coli: purification, reconstitution, and ligand binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

One-step refolding and purification of disulfide-containing proteins with a C-terminal MESNA thioester

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Crystal structure of the pertussis toxin-ATP complex: a molecular sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0317-6

Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.

21 January 2018

1 reference

12 December 2020

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

12 December 2020

Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies

1 reference

12 December 2020

Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin

1 reference

12 December 2020

Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin

1 reference

12 December 2020

Expression of UreB and HspA of Helicobacter pylori in silkworm pupae and identification of its immunogenicity

1 reference

12 December 2020

ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis

1 reference

12 December 2020

Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70(359-610) in prokaryotic system as a fusion protein

1 reference

12 December 2020

Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908

1 reference

12 December 2020

Historical review of pertussis and the classical vaccine

1 reference

12 December 2020

Protective activities in mice of monoclonal antibodies against pertussis toxin

1 reference

12 December 2020

Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin.

1 reference

12 December 2020

Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial

1 reference

12 December 2020

Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies.

1 reference

12 December 2020

Mutants of pertussis toxin suitable for vaccine development

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

14 December 2017

1033523402

0 references

1 reference